A Clinical Study to evaluate the Efficacy of Sombu theeneer and Sombu Theeneer with Siddhar Yoga Maruthuva Muraigal in the Management of Swasakasam (Bronchial asthma)

An open-labelled, double-arm, non-randomized Phase II clinical trial to evaluate the Efficacy of Sombu Theeneer and Sombu Theeneer with Siddhar yoga Maruthuva Muraigal in the management of Swasakasam (Bronchial asthma) - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104866

Enrollment

Registered

2026-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: Sombu Theeneer (Internal medicine): Oral administration of 20ml of Sombu Theeneer with Luke warm water twice a day for a duration of 48 days Control Intervention1: Sombu Theeneer with S

Eligibility

Inclusion criteria

Inclusion criteria: If any 3 of the following symptoms of asthma are present, the participants will be included for the study Mild and moderate (episodic) asthmatic symptoms Breathless Wheezing with unproductive cough When sputum is expelled by cough, the symptoms are relieved, otherwise dyspnea will be severe Obstructive sleep apnea Allergic rhinitis

Exclusion criteria

Exclusion criteria: Chronic bronchitis Pulmonary tuberculosis Sinusitis Interstitial lung disease Bronchiectasis Any other serious systematic illness Pregnant and lactation Patient who had allergy with trail drug

Design outcomes

Primary

Measure	Time frame
Evaluate the clinical efficacy of Sombu theeneer and Sombu Theeneer With Siddhar Yoga Maruthuva Muraigal in management of Swasakasam (Bronchial Asthma). To assess the Improvement in symptom scoring using standardized asthma control tool such as Asthma Control Test before and after the trail in both groupsTimepoint: Baseline(0th day) and the end of the intervention period (48th day)	—

Secondary

Measure	Time frame
To assess the improvement in lung function using Peak Expiratory Flow Rate (PEFR), measured with a peak flow meter before and after the intervention in both groups.Timepoint: Baseline(0th day) and the end of the intervention period (48th day)	—

Countries

India

Contacts

Public ContactDr V Mahalakshmi MD Siddha

Government Siddha Medical College and hospital Palayamkottai

drmahalakshmi67@gmail.com9942061169

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026